CTOs on the Move

Medical Litigation

www.medlitigation.com

 
Medical Litigation is a Lancaster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Microcopy Dental

Since its inception in 1970, Microcopy has been at the forefront in the design and development of diamond and carbide burs for the dental industry. Our NeoDiamond product line—America`s #1 selling diamond—is among the most respected in the dental marketplace. Our team of engineers, marketers and production experts design, package and perform complete product inspections following our ISO-certified quality management system. Because we are a full-service solution for our customers, we are able to provide unparalleled support complete with a 100% performance guarantee. Our mission at Microcopy is to provide a strong sense of satisfaction to each customer by offering truly innovative, effective, high-value products. This combined with a courteous and responsive customer service team is what keeps our loyal customers coming back and inspires them to spread the word about our products to their peers.

first valley medical group

first valley medical group is a Lancaster, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sightpath Medical

Sightpath Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dentsply Gac

Dentsply Gac is a Queensbury, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osiris Therapeutics

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.